The Immunosuppressant FTY720 (Fingolimod) enhances Glycosaminoglycan depletion in articular cartilage
<p>Abstract</p> <p>Background</p> <p>FTY720 (Fingolimod) is a novel immunosuppressive drug investigated in clinical trials for organ transplantation and multiple sclerosis. It acts as a functional sphingosine-1-phosphate (S1P) receptor antagonist, thereby inhibiting the...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-12-01
|
Series: | BMC Musculoskeletal Disorders |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2474/12/279 |